Key result
Dronedarone and amiodarone showed comparable efficacy in reducing atrial fibrillation frequency, though amiodarone restored sinus rhythm faster.
Why the study?
To compare the clinical efficacy of oral dronedarone versus amiodarone in treating paroxysmal AF using cardiac pacemaker monitoring.
Does oral dronedarone compared to amiodarone reduce the frequency of AF events in patients with paroxysmal AF and implanted pacemakers?
Cohort (n=140)
Does oral dronedarone compared to amiodarone reduce the frequency of AF events in patients with paroxysmal AF and implanted pacemakers?
Dronedarone and amiodarone show comparable efficacy in reducing AF episodes in patients with paroxysmal AF, with dronedarone offering fewer adverse effects and amiodarone providing faster restoration of sinus rhythm.
Answers are grounded in this paper and cite their sources.
May support dronedarone preference for fewer complications; leaves open confirmation by randomized trials in pacemaker patients.
目的:应用心脏起搏器监测,比较决奈达隆与胺碘酮口服治疗阵发性心房颤动(后简称房颤)的临床疗效。方法:纳入安装心脏起搏器的阵发性房颤患者140例,分为决奈达隆组(观察组,70例)和胺碘酮组(对照组,70例)。比较两组药物治疗后起搏器记录的房颤事件频率、持续时间及相关并发症。结果:治疗前两组基线数据无显著差异。治疗3个月和1年后,房颤发生次数显著下降(P Objective: To utilize cardiac pacemaker monitoring to compare the clinical efficacy of oral dronedarone and amiodarone in the treatment of paroxysmal atrial fibrillation (AF). Methods: A total of 140 patients with paroxysmal AF who had cardiac pacemakers implanted were enrolled. The patients were divided into a dronedarone group (observation group, 70 cases) and an amiodarone group (control group, 70 cases). The frequency and duration of AF events recorded by pacemakers, as well as related complications, were compared between the two groups after treatment. Results: Baseline data showed no significant difference between the two groups before treatment. After 3 months and 1 year of treatment, the frequency of AF episodes significantly decreased (P < 0.05), with no statistically significant differences between the two groups. The incidence of complications was lower in the observation group, but the time to restore sinus rhythm after an AF episode was significantly longer compared to the control group (P < 0.05). Conclusion: In the maintenance therapy for AF, dronedarone and amiodarone exhibit comparable efficacy. Dronedarone is associated with fewer adverse effects and better patient compliance. However, amiodarone demonstrates superior performance in restoring sinus rhythm.
No takes yet. Share an insight, caveat, or question.
志慧 王 (2025) conducted a cohort in paroxysmal atrial fibrillation (n=140). Dronedarone vs. Amiodarone was evaluated on Frequency and duration of atrial fibrillation events. Dronedarone and amiodarone showed comparable efficacy in reducing atrial fibrillation frequency, though amiodarone restored sinus rhythm faster.
Synapse has enriched 10 related papers. Consider them for comparative context: